VRDN - Viridian Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRDN is currently covered by 14 analysts with an average price target of $30.03. This is a potential upside of $18.04 (150.46%) from yesterday's end of day stock price of $11.99.

Viridian Therapeutics's activity chart (see below) currently has 23 price targets and 88 ratings on display. The stock rating distribution of VRDN is 94.29% BUY and 5.71% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 15.18% with an average time for these price targets to be met of 108.88 days.

Highest price target for VRDN is $61, Lowest price target is $22, average price target is $39.62.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 07-Jan-2025. First documented stock forecast 20-Jan-2021.

Currently out of the existing stock ratings of VRDN, 66 are a BUY (94.29%), 4 are a HOLD (5.71%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$38

$26.01 (216.93%)

$38

2 months 30 days ago
(07-Jan-2025)

0/14 (0%)

$17.09 (81.73%)

Hold

$27

$15.01 (125.19%)

$37

3 months 18 days ago
(19-Dec-2024)

0/2 (0%)

$8.27 (44.15%)

Buy

$47

$35.01 (291.99%)

$44

3 months 20 days ago
(17-Dec-2024)

0/11 (0%)

$26.18 (125.74%)

Buy

$34

$22.01 (183.57%)

$34

3 months 21 days ago
(16-Dec-2024)

1/14 (7.14%)

$12.46 (57.85%)

40

Buy

$41

$29.01 (241.95%)

$40

4 months 25 days ago
(12-Nov-2024)

0/4 (0%)

$18.57 (82.79%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRDN (Viridian Therapeutics) average time for price targets to be met?

On average it took 108.88 days on average for the stock forecasts to be realized with a an average price target met ratio 15.18

Which analyst has the current highest performing score on VRDN (Viridian Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on VRDN (Viridian Therapeutics)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on VRDN

Which analyst is the currently most bullish on VRDN (Viridian Therapeutics)?

Julian Harrison with highest potential upside - $49.01

Which analyst is the currently most reserved on VRDN (Viridian Therapeutics)?

Michael Higgins with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?